hrp0082p3-d3-728 | Diabetes (2) | ESPE2014

The Result of Sulphonylureas Treatment in Patients with Neonatal Diabetes Mellitus due to kcnj11/abcc8 Gene Mutations in Vietnam

Bich Ngoc Can Thi , Chi Dung Vu , Phuong Thao Bui , Ngoc Khanh Nguyen , Phu Dat Nguyen , Ellard Sian , Craig Maria , Thi Hoan Nguyen

Background: Neonatal diabetes may be defined as hyperglycemia diagnosed within the first 6 months of life which is permanent neonatal diabetes or transient neonatal diabetes. They can result from some gene mutations such as KCNJ11, ABCC8, INS, GCK, … In there, the most common cause of neonatal diabetes mellitus is associated with activating mutations in the KCNJ11 gene, which encodes Kir6.2-a subunit of the ATP-sensitive potassium channel (KATP) of the β cell and AB...

hrp0095p2-186 | Growth and Syndromes | ESPE2022

Effect of Growth Hormone Therapy on Height in Children: Idiopathic Gh Deficient, Family Short Stature, Small for Gestational Age

Huynh Thoai Loan , LE Thi Ngoc , Nguyen Lac Han

Objective: To investigate response to growth hormone (GH) treatment for idiopathic GH deficient (GHD) and family short stature (FSS) and Small for Gestational Age (SGA) patients or Combined group.Design: GHD, FSS, SGA and Combined group patients who were currently receiving GH and had completed treatment with treatment duration of more than 6 months (from 8/2019 to 5/2021) at International Vinmec Central Park hospital. M...

hrp0095p2-232 | Pituitary, Neuroendocrinology and Puberty | ESPE2022

Clinical and Para Clinical Features, Effect Oftriptoreline 11.25 Mg Every 3 Months in Patients with Central Precocious Puberty After 6 Months of Treatment

Huynh Thoai Loan , Le Hong Anh , Nguyen Lac Han

Background: Precocious puberty is defined by the development of secondary sexual characteristics before the age of 8 in girls and before the age of 9 in boys. if not diagnosed and treated at an early stage, precocious puberty can compromise final adult height and trigger psychological disturbances. Gonadotropin- releasing hormone analogs (GnRHa) contributes to achievement of target final height by reducing the acceleration of bone maturation.<p class="abst...

hrp0089p3-p099 | Diabetes &amp; Insulin P3 | ESPE2018

Case Report: De Novo Mutation of Foxp3 Causing Mild Phenotype of Immunodysregulation, Polyendocrinopathy, Enteropathy, X-Link Syndrome

Thuy Hoang Thi Diem , Minh Nguyen Khoa Binh

Immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome (IPEX) is caused by mutations in the gene that encode for the transcription factor FOXP3. IPEX is a rare, often fatal disease. However, several cases present later onset, mild forms or less common clinical manifestations. We report a case who had de novo mutation of FOXP3 causing neonatal diabetes but without other features of IPEX syndrome. An 8 days old male, late preterm at 36 weeks, low birthweight 2200g...

hrp0089p3-p316 | Pituitary, Neuroendocrinology and Puberty P3 | ESPE2018

The Efficacy of Treatment in Vietnamese Children with Central Precocious Puberty

Tuong Vy Vo , Huy Luan Nguyen , Vu Quynh Huynh Thi

Background: Central Precocious Puberty (CPP) may be lead to consequences such as limitation adult stature, sexual abuse, and emotional distress. GnRH agonist therapy in patients with CPP has been demonstrated in increasing adult height and improving emotional distress in puberty stage.Objective: Evaluating the efficacy of treatment in patients with central precocious puberty after one year in Children Hospital 2, Vietnam in 7 years, from 01/2017 to 12/20...

hrp0094p2-66 | Bone, growth plate and mineral metabolism | ESPE2021

Vosoritide Clinical Study Data Demonstrates CXM is a Superior Biomarker of Endochondral Bone Growth

Larimore Kevin , Nguyen Thom , Qi Yulan , Jeha George , Zoog Stephen ,

Vosoritide is a C-type Natriuretic Peptide (CNP) analogue therapy for treatment of achondroplasia. Vosoritide acts on growth plate chondrocytes through the Natriuretic Peptide Receptor-B to stimulate increased endochondral bone growth, leading to increased growth velocity in treated subjects. In Phase II clinical studies, subject blood and urine samples were analyzed to monitor putative bone growth biomarkers including cross-linked C-terminal telopeptides of collagen II (CTxII...

hrp0084p3-690 | Diabetes | ESPE2015

Neonatal Diabetes Mellitus: Clinical Feature and Outcome

Thi Bich Ngoc Can , Chi Dung Vu , Phuong Thao Bui , Ngoc Khanh Nguyen , Craig Maria , Ellard Sian , Thi Hoan Nguyen

Background: Neonatal diabetes mellitus (NDM) is a rare (1:300 000–400 000 newborns) but potentially devastating metabolic disorder characterized by hyperglycemia combined with low levels of insulin. Two main groups have been recognized on clinical grounds, transient NDM (TNDM) and permanent NDM (PNDM).Objective and hypotheses: To describe clinical features and laboratory manifestations of patient with NDM and evaluate outcome of management.<p cl...

hrp0084p3-726 | Diabetes | ESPE2015

Neonatal Diabetes Mellitus due to Insulin Gene Mutation

Thi Bich Ngoc Can , Chi Dung Vu , Phuong Thao Bui , Ngoc Khanh Nguyen , Craig Maria , Ellard Sian , Thi Hoan Nguyen

Background: Neonatal diabetes is a rare disorder with an incidence of between 1 in 215 000–500 000 live births with approximately 50% having permanent neonatal diabetes (PNDM). Insulin gene (INS) mutations have recently been described as a cause of PNDM.Objective and hypotheses: To describe clinical features and laboratory manifestations of patient with PNDM due to INS gene mutation and evaluate outcome of management....

hrp0095p1-47 | Diabetes and Insulin | ESPE2022

Congenital hyperinsulinism: a case with a missense monoallelic heterozygous ABCC8 mutation responsive partially to diazoxide therapy

Tien Son Do , Phuong Thao Bui , Ngoc Khanh Nguyen , Thi Bich Ngoc Can , Hoang Lan Nguyen , Thi Tu Anh Dao , Trong Thanh Nguyen , Thi Thanh Mai Do , Thi Anh Thuong Tran , Chi Dung Vu

Congenital hyperinsulinism (CHI) is a rare hereditary condition that causes excessive insulin production in the clinical picture of severe hypoglycemia. Patients with CHI frequently have mutations in the ABCC8 and KCNJ11 genes, which code for KATP channels in pancreatic beta cells. We present a case of partial diazoxide responsiveness caused by a heterozygous ABCC8 mutation in a child with moderate CHI. A four-month-old term baby with a ...

hrp0092p3-141 | GH and IGFs | ESPE2019

Treatment Outcome of Growth Hormone in Turner Syndrome Children

Thao Bui Phuong , Dung Vu Chi , Nhu Hoa Pham Thi , Khanh Nguyen Ngoc , Bich Ngoc Can Thi , Mai Do Thi Thanh , Ha Nguyen Thu

Background: Turner syndrome (TS) patients frequently have short stature. Females adults with TS are usually 20 cm shorter than normal females. Growth hormone (GH) can improve final height in TS patients.Objective: To evaluate GH therapy for children with Turner syndrome in term of efficacy and side effectPatient and Method: This serial cases study was done in TS patients in a perio...